| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.01B | 43.46B | 39.16B | 49.41B | 58.85B | 37.93B |
| Gross Profit | 13.89B | 15.93B | 11.10B | 17.29B | 20.87B | 16.07B |
| EBITDA | 1.30B | 2.19B | 1.06B | 4.68B | 12.54B | 14.45B |
| Net Income | -1.99B | -1.10B | -1.58B | 1.52B | 6.49B | 4.10B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 65.03B | 60.30B | 58.37B | 56.01B | 44.86B |
| Cash, Cash Equivalents and Short-Term Investments | 5.87B | 5.87B | 7.31B | 11.30B | 10.21B | 3.24B |
| Total Debt | 0.00 | 18.42B | 15.48B | 10.19B | 8.81B | 21.27B |
| Total Liabilities | -20.68B | 44.35B | 43.30B | 39.78B | 38.96B | 48.36B |
| Stockholders Equity | 20.68B | 20.68B | 17.01B | 18.58B | 17.05B | -3.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.11B | -8.64B | -641.60M | 7.88B | 10.21B |
| Operating Cash Flow | 0.00 | 1.72B | -2.45B | 3.55B | 9.01B | 10.76B |
| Investing Cash Flow | 0.00 | -4.07B | -5.24B | -2.17B | 1.08B | 21.52B |
| Financing Cash Flow | 0.00 | 660.90M | 3.82B | -269.90M | -3.13B | -30.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹68.54B | 10.83 | ― | 3.68% | -7.53% | 42.74% | |
67 Neutral | ₹44.81B | 13.14 | ― | 0.46% | 8.51% | 32.37% | |
66 Neutral | ₹51.00B | 10.00 | ― | 2.10% | -5.14% | 7.25% | |
65 Neutral | ₹58.82B | 20.51 | ― | 0.47% | 5.61% | 33.63% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ₹69.79B | 40.78 | ― | 0.78% | -3.15% | -22.30% | |
41 Neutral | ₹41.20B | -18.88 | ― | ― | 6.50% | -70.69% |
Chemplast Sanmar Limited has responded to a query from the National Stock Exchange of India regarding a recent significant movement in its share price and trading volumes. The company stated that it is not aware of any undisclosed events or price-sensitive information, beyond what is already in the public domain, that would materially affect its operations or performance, indicating that the recent stock volatility is not driven by any non-public corporate developments.
Chemplast Sanmar Limited has announced an upcoming earnings conference call scheduled for November 14, 2025, to discuss its operational and financial performance for the second quarter and the first half of the fiscal year 2026. This call is significant for stakeholders as it provides insights into the company’s financial health and strategic direction, potentially impacting investor decisions and market positioning.